PET may be imaging alternative during radiotracer shortage, says ASNC president | Group warns of medications that may trigger, worsen heart failure | Dietary omega-3 fatty acids may reduce risk of fatal cardiac event
July 13, 2016
News for nuclear cardiology and cardiovascular imaging professionals
ASNC President Dr. Brian Abbott says adopting cardiac PET could be a solution to the shortage of radiotracer technetium-99m for SPECT-MPI. He said shortages may continue, and PET imaging with rubidium-82, which is widely available, may be a good alternative.
The American Heart Association has released a scientific statement warning about the risks of using metformin, nonsteroidal anti-inflammatory drugs, antihypertensive drugs, and other prescription and over-the-counter drugs and complementary and alternative medications that may cause or exacerbate heart failure. The group recommends educating patients about the impact of OTC and alternative medications, encouraging them to actively take part in managing their medications, and establishing a "captain" among a patient's clinicians to oversee and monitor medications.
The Basics of Encryption and Compliance Do you know why data encryption is important for your business? Read this ebook to see how using advance encryption lets you support your compliance with multiple regulations while meeting clients' expectations, protect your data and reputation, and eliminate paperwork and other overhead.
Download the free ebook now.
Middle-aged and older adults without a history of heart disease had a lower risk of a fatal cardiac event over 10 years if they had higher levels of omega-3 polyunsaturated fatty acids from eating fish and plant-based foods, researchers wrote in JAMA Internal Medicine. The report included data from 19 studies involving 45,637 people from 16 countries, including the US.
Researchers followed over 1,000 patients in Minnesota who experienced heart attack and found those who also had heart failure had about 71% higher odds of developing cancer, compared with heart attack survivors without the condition. The findings, published in the Journal of the American College of Cardiology, showed that patients with heart failure had particularly higher rates of respiratory and digestive cancers.
A once-a-month dose of Amgen's PCSK9 inhibitor Repatha, or evolocumab, has been approved by the FDA as a treatment to control LDL cholesterol. The drug can now be self-administered with the Pushtronex device to release a single subcutaneous dose of 420 mg.
Writing in the Journal of the American Medical Association, President Barack Obama urged Congress to revisit the idea of a "public option" for health coverage under the Affordable Care Act. Obama also called on lawmakers to do more to fight prescription drug costs, and he pressed states that have not expanded Medicaid eligibility to do so.
The Journal of Nuclear Cardiology is the only journal in the world devoted to the dynamic and growing subspecialty of nuclear cardiology. Physicians and technologists value the journal not only for its peer-reviewed articles, but also for its timely discussions about the current and future role of nuclear cardiology. Original articles address all aspects of nuclear cardiology, including interpretation, diagnosis, imaging equipment and use of radiopharmaceuticals. As the official publication of ASNC, the journal also brings readers the latest information emerging form the society's task forces and publishes guidelines and position papers as they are adopted. Receive full journal access with an ASNC membership.
The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the fourth in a series of complimentary webinars on Wednesday, July 20, at 9:00 p.m. (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians. The session will provide an overview of the importance of reporting a myocardial perfusion SPECT study accurately and in compliance with the guidelines. The use of structured data, structured reporting and the important role they play in registries will be discussed. Learn more and register.